Stock listing
B43 Stock Price, News, Filings & Events — First Tracks Biotherapeutics, Inc.
Selected listing: B43 · DUS · USD · DE
This page tracks First Tracks Biotherapeutics, Inc.'s B43:DUS listing on DUS in USD for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following B43:DUS. B43:DUS is the stock-level entry point for investors researching First Tracks Biotherapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- B43:DUS
- Asset type
- Stock
- Market cap
- $1.30B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- DUS
- Currency
- USD
First Tracks Biotherapeutics, Inc. B43:DUS stock context
This page tracks First Tracks Biotherapeutics, Inc.'s B43:DUS listing on DUS in USD for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following B43:DUS. B43:DUS is the stock-level entry point for investors researching First Tracks Biotherapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from First Tracks Biotherapeutics, Inc.
First Tracks Biotherapeutics Announces Participation in September Investor Conferences
August 26, 2026
First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
August 12, 2026
First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences
May 21, 2026
First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases
April 20, 2026
Research First Tracks Biotherapeutics, Inc.
First Tracks Biotherapeutics, Inc. investor report
Review AI stock analysis and investor report context for B43:DUS.
First Tracks Biotherapeutics, Inc. company profile
View the public company page for First Tracks Biotherapeutics, Inc. on 6ix.
First Tracks Biotherapeutics, Inc. news
Read company news and market updates connected to First Tracks Biotherapeutics, Inc..
First Tracks Biotherapeutics, Inc. investor events
Find investor webinars, events, and replay context for First Tracks Biotherapeutics, Inc..
Alternate listings
TRAX:NASDAQ
US · USD
Alternate listing for First Tracks Biotherapeutics, Inc.; the primary context on this page is B43:DUS.
TRAX:BMV
MX · MXN
Alternate listing for First Tracks Biotherapeutics, Inc.; the primary context on this page is B43:DUS.
TRAX:BOATS
US · USD
Alternate listing for First Tracks Biotherapeutics, Inc.; the primary context on this page is B43:DUS.
TRAX:BIVA
MX · MXN
Alternate listing for First Tracks Biotherapeutics, Inc.; the primary context on this page is B43:DUS.
B43:HAM
DE · EUR
Alternate listing for First Tracks Biotherapeutics, Inc.; the primary context on this page is B43:DUS.